西,使""

Shravan V Savant1, James T Kwan2, Fina Barouch1

  • 1Department of Ophthalmology, Beth Israel Lahey Health, Burlington, Massachusetts, USA.

Journal of ophthalmology
|November 12, 2024
PubMed
概括

在治疗和延长方案中切换到内法里西马布注射 (IFI) 改善了治疗间隔,并减少了治疗耐药的神经血管年龄相关黄斑变性或糖尿病黄斑胀的患者的视网膜液.